University of Pittsburgh, Pittsburgh, PA, USA.
UPMC Hillman Cancer Center, 5200 Centre Avenue, Suite 604, Pittsburgh, PA, 15232, USA.
Support Care Cancer. 2019 Feb;27(2):591-600. doi: 10.1007/s00520-018-4346-3. Epub 2018 Jul 19.
Given the complexities and risks of allogeneic HCT, patients and their family caregivers may experience elevated psychological distress, including symptoms of anxiety and depression, in anticipation of the procedure. Patients and caregivers also bring with them their pre-HCT experiences of diagnosis, prior treatment, and associated burdens, thus potentially compounding their acute distress. Identification of clinical, psychosocial, and sociodemographic factors related to pre-HCT distress would allow targeting of patients and caregivers who may require assistance during the HCT process.
Consecutive patients (n = 111) and their caregivers (n = 110) completed measures of anxiety, depression, cancer distress, perceived threat, perceived control, self-efficacy, relationship quality, and physical quality of life in the week before HCT. Multivariate linear regression analysis was used to identify factors associated with patient and caregiver anxiety or depression, including disease type, donor type, and patient and caregiver sociodemographic, health-related, and psychosocial factors.
Family caregivers had higher levels of anxiety and depression symptoms than patients. Thirty percent of caregivers vs. 17% of patients met criteria for clinically significant anxiety and a lesser amount (5% for both) met criteria for clinically significant depression. Patient anxiety was related to younger age (b = - 0.22, p = 0.005) and greater cancer-related distress (b = 0.59, p < 0.001), while caregiver anxiety was related to lower self-efficacy (b = - 0.19, p = 0.011) and greater cancer-related distress (b = 0.58, p < 0.001). Similarly, patient depression was related to lower perceived control (b = - 0.17, p = 0.050), greater cancer-related distress (b = 0.34, p = 0.005), and lower physical functioning (b = - 0.26, p = 0.008), while caregiver depression was related to greater cancer-related distress (b = 0.46, p < 0.001).
Family caregivers may be more emotionally vulnerable than patients before HCT and in need of additional assistance. Cancer-related distress was the strongest correlate of anxiety and depression in both patients and caregivers, suggesting that distress related to their cancer experience and its consequences plays a major role in their emotional functioning prior to HCT.
鉴于异基因造血细胞移植的复杂性和风险,患者及其家属在接受该治疗前可能会经历更高水平的心理困扰,包括焦虑和抑郁症状。此外,患者及其家属还带来了他们在移植前的诊断、前期治疗和相关负担的经历,这可能会使他们的急性痛苦更加复杂。确定与移植前痛苦相关的临床、心理社会和社会人口学因素,将有助于确定在移植过程中可能需要帮助的患者和家属。
连续纳入 111 名患者及其 110 名家属,在移植前一周内完成焦虑、抑郁、癌症困扰、感知威胁、感知控制、自我效能、关系质量和身体生活质量的评估。采用多元线性回归分析确定与患者和家属焦虑或抑郁相关的因素,包括疾病类型、供者类型以及患者和家属的社会人口学、健康相关和心理社会因素。
与患者相比,家属的焦虑和抑郁症状水平更高。30%的家属表现出焦虑症状,而 17%的患者表现出焦虑症状,符合临床显著焦虑的标准(两者都较少,为 5%)。患者的焦虑与年龄较小(b= -0.22,p=0.005)和癌症相关困扰较大(b=0.59,p<0.001)有关,而家属的焦虑与自我效能较低(b= -0.19,p=0.011)和癌症相关困扰较大(b=0.58,p<0.001)有关。同样,患者的抑郁与感知控制较低(b= -0.17,p=0.050)、癌症相关困扰较大(b=0.34,p=0.005)和身体功能较低(b= -0.26,p=0.008)有关,而家属的抑郁与癌症相关困扰较大(b=0.46,p<0.001)有关。
在接受造血细胞移植前,家属可能比患者更脆弱,需要额外的帮助。癌症相关困扰是患者和家属焦虑和抑郁的最强相关因素,这表明与癌症经历及其后果相关的困扰在他们接受造血细胞移植前的情绪功能中起着重要作用。